Inflammation and oxidative stress in diabetic kidney disease: the targets for SGLT2 inhibitors and GLP-1 receptor agonists

A Winiarska, M Knysak, K Nabrdalik… - International Journal of …, 2021 - mdpi.com
The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney
disease (DKD) remains one of the leading long-term complications of T2D. Several lines of …

Epithelial–mesenchymal transition in organ fibrosis development: current understanding and treatment strategies

L Liu, Q Sun, F Davis, J Mao, H Zhao, D Ma - Burns & Trauma, 2022 - academic.oup.com
Organ fibrosis is a process in which cellular homeostasis is disrupted and extracellular
matrix is excessively deposited. Fibrosis can lead to vital organ failure and there are no …

Renal fibrosis in lupus nephritis

S Sciascia, M Cozzi, A Barinotti, M Radin… - International Journal of …, 2022 - mdpi.com
Fibrosis can be defined as a pathological process in which deposition of connective tissue
replaces normal parenchyma. The kidney, like any organ or tissue, can be impacted by this …

Lysyl oxidase like-2 in fibrosis and cardiovascular disease

A Poe, M Martinez Yus, H Wang… - American Journal of …, 2023 - journals.physiology.org
Fibrosis is an important and essential reparative response to injury that, if left uncontrolled,
results in the excessive synthesis, deposition, remodeling, and stiffening of the extracellular …

Hypoxia-inducible factors and diabetic kidney disease—How deep can we go?

AM Stanigut, C Pana, M Enciu, M Deacu… - International Journal of …, 2022 - mdpi.com
Diabetes is one of the leading causes of chronic kidney disease (CKD), and multiple
underlying mechanisms involved in pathogenesis of diabetic nephropathy (DN) have been …

Long non-coding RNA lnc-CHAF1B-3 promotes renal interstitial fibrosis by regulating EMT-related genes in renal proximal tubular cells

K Imai, T Ishimoto, T Doke, T Tsuboi… - … Therapy-Nucleic Acids, 2023 - cell.com
Renal interstitial fibrosis (RIF) is a common pathological manifestation of chronic kidney
diseases. Epithelial-mesenchymal transition (EMT) of tubular epithelial cells is considered a …

Hydrogel and nanoparticle carriers for kidney disease therapy: trends and recent advancements

X Gu, Z Liu, Y Tai, L Zhou, K Liu, D Kong… - Progress in …, 2022 - iopscience.iop.org
Achieving local therapeutic agent concentration in the kidneys through traditional systemic
administration routes have associated concerns with off-target drug effects and toxicity …

[HTML][HTML] Tackling the effects of extracellular vesicles in fibrosis

M Martín-Taboada, P Corrales… - European Journal of …, 2022 - Elsevier
Fibrosis is a physiological process of tissue repair that turns into pathological when
becomes chronic, damaging the functional structure of the tissue. In this review we outline …

[Retracted] Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy

F Zheng, P Zhang, M Zhao, J Wang… - … Methods in Medicine, 2022 - Wiley Online Library
Objective. We investigated the effect of roxadustat on factors associated with renal fibrosis
and efficacy. Methods. Sixty patients meeting the inclusion criteria between January 2021 …

Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases

J Sarrand, MS Soyfoo - International Journal of Molecular Sciences, 2023 - mdpi.com
Epithelial-mesenchymal transition (EMT) is a complex reversible biological process
characterized by the loss of epithelial features and the acquisition of mesenchymal features …